Newsfiscal.ai
NanoViricides Announces Positive Safety and Toxicology Results for NV-387 in Juvenile Animal Study
· Published
Article summary
NanoViricides, Inc. reported that its broad-spectrum antiviral drug candidate, NV-387, demonstrated strong safety and tolerability in a juvenile mouse pup study, supporting potential future pediatric clinical trials.
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…